Joel Goldberg Biography and Net Worth

Insider of Revvity

Joel S. Goldberg joined PerkinElmer in July 2008 as senior vice president, general counsel and secretary.
Before joining PerkinElmer, Goldberg spent seven years at Millennium Pharmaceuticals, Inc. where he most recently served as vice president, chief compliance officer and secretary. Prior to this, Goldberg was an associate of the law firm Edwards & Angell, LLP.
Goldberg graduated from the Northeastern University School of Law and also holds a Masters in Business Administration for Northeastern. He completed his undergraduate degree at the University of Wisconsin-Madison.

What is Joel S. Goldberg's net worth?: The estimated net worth of Joel S. Goldberg is at least $0.00 as of July 31st, 2020. Mr. Goldberg owns 95,179 shares of Revvity stock worth more than $0 as of April 25th. This net worth evaluation does not reflect any other assets that Mr. Goldberg may own. Learn More about Joel S. Goldberg's net worth.
How do I contact Joel S. Goldberg?: The corporate mailing address for Mr. Goldberg and other Revvity executives is 940 WINTER STREET, WALTHAM MA, 02451. Revvity can also be reached via phone at (781) 663-6900 and via email at [email protected]. Learn More on Joel S. Goldberg's contact information.
Has Joel S. Goldberg been buying or selling shares of Revvity?: Joel S. Goldberg has not been actively trading shares of Revvity over the course of the past ninety days. Most recently, Joel S. Goldberg sold 23,387 shares of the business's stock in a transaction on Friday, July 31st. The shares were sold at an average price of $117.84, for a transaction totalling $2,755,924.08. Following the completion of the sale, the insider now directly owns 95,179 shares of the company's stock, valued at $11,215,893.36. Learn More on Joel S. Goldberg's trading history.
Who are Revvity's active insiders?: Revvity's insider roster includes Peter Barrett (Director), Joel Goldberg (Insider), Sylvie Gregoire (Director), Maxwell Krakowiak (Insider), James Mock (Insider), Andrew Okun (Insider), Prahlad Singh (Insider), Daniel Tereau (Insider), and Tajinder Vohra (Insider). Learn More on Revvity's active insiders.

Joel S. Goldberg Insider Trading History at Revvity

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/31/2020	Sell	23,387	$117.84	$2,755,924.08	95,179
3/11/2019	Sell	24,465	$92.81	$2,270,596.65	84,277
8/2/2018	Sell	34,608	$85.00	$2,941,680.00
3/13/2017	Sell	30,710	$55.45	$1,702,869.50	91,768
9/22/2016	Sell	38,095	$55.00	$2,095,225.00	96,299
3/27/2015	Sell	10,646	$51.00	$542,946.00
3/18/2015	Sell	9,000	$49.00	$441,000.00
3/5/2015	Sell	9,000	$47.00	$423,000.00
6/2/2014	Sell	17,000	$45.11	$766,870.00

Joel S. Goldberg Buying and Selling Activity at Revvity

Revvity Company Overview

Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.

Today's Range

Now: N/A

50 Day Range

MA: $127.73

$115.24

$137.11

2 Week Range

Now: N/A

Volume

1,633,000 shs

Average Volume

851,117 shs

Market Capitalization

$14.57 billion

P/E Ratio

15.01

Dividend Yield

0.24%

Beta

1.1

Thousands of investors use this no cost solution | Do you?

From Insider Financial | Ad

In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.

Simply tap here now to subscribe and start getting "Insider Financial Advantage"